Renaissance Capital logo

KNW News

US IPO Weekly Recap: Billion-dollar deal Corebridge completes 2022’s largest IPO to date

CRBG

Six issuers began trading this past week, four of which will be included in our stats. The most notable debuts included Corebridge Financial (CRBG) and Third Harmonic Bio (THRD). The pipeline was also active, with seven IPOs and two SPACs submitting initial filings. AIG carve-out Corebridge priced at the low end to raise $1.7...read more

Glucose monitor developer Know Labs prices upsized NYSE American uplisting at $2

KNW

Know Labs, which is developing a non-invasive glucose monitor using biosensor technology, raised $7 million by offering 3.6 million shares at $2, below the last close of its shares on the OTC ($2.53). The company offered 0.6 million more shares than anticipated. Formerly listed on the Know Labs is focused on the development and commercialization of proprietary biosensor...read more

US IPO Week Ahead: Corebridge plots the year’s largest IPO

CRBG

Six deals are expected to begin trading in the week ahead, though only five meet the criteria for our IPO stats. The group is led by AIG carve-out Corebridge Financial (CRBG) and biotech Third Harmonic Bio (THRD). In what could be the largest deal of 2022 so far, Corebridge plans to raise $1.8 billion at a fully diluted market...read more

US IPO Week Ahead: Quiet IPO calendar primed for post-Labor Day launches

KNW

Just two small deals are currently on the calendar, though other companies may join the September lineup in the short week ahead. OTC-listed Know Labs (KNW) plans to raise $6 million at a $123 million market cap. Know Labs is focused on the development and commercialization of proprietary biosensor technologies. The early-stage company is initially using...read more